MindNetwork (FHE) 24-hour volatility at 49.5%: Low market cap speculative rebound amid 116% surge in trading volume
Bitget Pulse2026/04/18 17:46Brief Volatility Overview
In the past 24 hours, FHE price rebounded from a low of $0.01958 to a high of $0.02844, currently quoted around $0.02150, with a total fluctuation amplitude of 49.5%. Trading volume surged to $12.42 million, an increase of 116.66% compared to the previous period, but there was a net outflow of approximately $22,000 in funds (mainly from CEX).
Analysis of Causes for Unusual Movement
- Trading volume increased sharply by 116.66%, along with a rapid rise and subsequent pullback in price, reflecting high speculative activity and volatility for a low market cap (approximately $5 million).
- Increased community discussions mentioning Binance, Chainlink endorsements, and potential “scam pump” opportunities, but no official announcements or on-chain whale movements were observed.
Market Views and Outlook
Community sentiment is mostly bullish, with CoinGecko showing 100% optimism; trading signals on X are mixed, with short-term support seen around $0.017 for a rebound, but warnings about low liquidity risks and possible “pump-dump” scenarios. Mainstream forecasts rely on FHE privacy narrative for long-term value.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
